CAS 137330-13-3, also known as Clonidine, is an important chemical compound used across various industries primarily for its pharmacological properties. This article explores the key applications of CAS 137330-13-3, providing relevant statistics and insights into its uses within medicine and other fields.
If you want to learn more, please visit our website CAS 137330-13-3.
Clonidine is primarily recognized as an antihypertensive agent. It functions as a centrally acting alpha-2 adrenergic agonist, which means it stimulates alpha-2 adrenergic receptors in the brain, leading to a decrease in blood pressure. According to the American Heart Association, approximately 108 million adults in the United States experience high blood pressure, making effective treatments like Clonidine vital for managing this widespread condition.
In addition to its primary application in hypertension management, CAS 137330-13-3 is utilized in various other medical scenarios. It is commonly prescribed for attention-deficit hyperactivity disorder (ADHD), where it helps alleviate symptoms such as hyperactivity and impulsivity. A study published in the Journal of the American Academy of Child and Adolescent Psychiatry reported that Clonidine could significantly reduce ADHD symptoms in children when compared to a placebo, thus expanding its relevance in pediatric medicine.
Another key application for CAS 137330-13-3 is in the management of opioid withdrawal symptoms. Clonidine can assist in reducing the severity of withdrawal symptoms, making it a critical component of comprehensive treatment programs for individuals overcoming opioid addiction. According to the National Institute on Drug Abuse, in 2021, about 1.6 million people had an opioid use disorder, illustrating the demand for effective treatment methods such as those involving Clonidine.
In the context of anesthesia, CAS 137330-13-3 is also utilized as part of pre-anesthetic medication protocols. It can facilitate sedation and reduce the amount of anesthetic required during surgeries. Research published in Anesthesia & Analgesia highlights that Clonidine not only minimizes the volume of anesthetic needed but can also improve patient outcomes by providing better cardiovascular stability during procedures.
Intriguingly, CAS 137330-13-3 has found applications beyond traditional medical uses. It is also being explored in the field of veterinary medicine. For instance, Clonidine can be used in managing anxiety and pain in animals, broadening its scope of application. A study in the Journal of Veterinary Emergency and Critical Care discusses the use of Clonidine for sedation in dogs, showcasing its effectiveness in veterinary settings.
Additionally, recent research has indicated potential applications of CAS 137330-13-3 in treating anxiety disorders, particularly generalized anxiety disorder (GAD). Preliminary studies suggest that Clonidine may play a beneficial role in alleviating anxiety symptoms, thus warranting further investigation in clinical settings. As mental health awareness grows, there is a rising interest in finding medications that can effectively address anxiety, making Clonidine a noteworthy candidate.
In summary, CAS 137330-13-3 exhibits a wide range of applications that span various fields, primarily focused on its medicinal properties. Its effectiveness in treating hypertension, ADHD, opioid withdrawal, and its role in anesthesia underscore its importance in modern healthcare. Furthermore, its emerging uses in veterinary medicine and potential applications for anxiety disorders illustrate the versatility of Clonidine as a vital compound in pharmacotherapy.
By summarizing the key applications of CAS 137330-13-3, this article highlights its significance in both human and veterinary medicine. This compound continues to play a critical role in addressing a variety of health issues, showcasing its ongoing relevance in contemporary medical practices.
Goto Acewell to know more.
CAS 137330-13-3, also known as Clonidine, is an important chemical compound used across various industries primarily for its pharmacological properties. This article explores the key applications of CAS 137330-13-3, providing relevant statistics and insights into its uses within medicine and other fields.
Clonidine is primarily recognized as an antihypertensive agent. It functions as a centrally acting alpha-2 adrenergic agonist, which means it stimulates alpha-2 adrenergic receptors in the brain, leading to a decrease in blood pressure. According to the American Heart Association, approximately 108 million adults in the United States experience high blood pressure, making effective treatments like Clonidine vital for managing this widespread condition.
In addition to its primary application in hypertension management, CAS 137330-13-3 is utilized in various other medical scenarios. It is commonly prescribed for attention-deficit hyperactivity disorder (ADHD), where it helps alleviate symptoms such as hyperactivity and impulsivity. A study published in the Journal of the American Academy of Child and Adolescent Psychiatry reported that Clonidine could significantly reduce ADHD symptoms in children when compared to a placebo, thus expanding its relevance in pediatric medicine.
Another key application for CAS 137330-13-3 is in the management of opioid withdrawal symptoms. Clonidine can assist in reducing the severity of withdrawal symptoms, making it a critical component of comprehensive treatment programs for individuals overcoming opioid addiction. According to the National Institute on Drug Abuse, in 2021, about 1.6 million people had an opioid use disorder, illustrating the demand for effective treatment methods such as those involving Clonidine.
In the context of anesthesia, CAS 137330-13-3 is also utilized as part of pre-anesthetic medication protocols. It can facilitate sedation and reduce the amount of anesthetic required during surgeries. Research published in Anesthesia & Analgesia highlights that Clonidine not only minimizes the volume of anesthetic needed but can also improve patient outcomes by providing better cardiovascular stability during procedures.
Intriguingly, CAS 137330-13-3 has found applications beyond traditional medical uses. It is also being explored in the field of veterinary medicine. For instance, Clonidine can be used in managing anxiety and pain in animals, broadening its scope of application. A study in the Journal of Veterinary Emergency and Critical Care discusses the use of Clonidine for sedation in dogs, showcasing its effectiveness in veterinary settings.
Additionally, recent research has indicated potential applications of CAS 137330-13-3 in treating anxiety disorders, particularly generalized anxiety disorder (GAD). Preliminary studies suggest that Clonidine may play a beneficial role in alleviating anxiety symptoms, thus warranting further investigation in clinical settings. As mental health awareness grows, there is a rising interest in finding medications that can effectively address anxiety, making Clonidine a noteworthy candidate.
In summary, CAS 137330-13-3 exhibits a wide range of applications that span various fields, primarily focused on its medicinal properties. Its effectiveness in treating hypertension, ADHD, opioid withdrawal, and its role in anesthesia underscore its importance in modern healthcare. Furthermore, its emerging uses in veterinary medicine and potential applications for anxiety disorders illustrate the versatility of Clonidine as a vital compound in pharmacotherapy.
By summarizing the key applications of CAS 137330-13-3, this article highlights its significance in both human and veterinary medicine. This compound continues to play a critical role in addressing a variety of health issues, showcasing its ongoing relevance in contemporary medical practices.
For more information, please visit Acewell.